# EDGAR Filing Document

**Accession Number:** 0001904501
**File Stem:** 0001062993-26-001166
**Filing Date:** 2026-2
**Character Count:** 5892
**Document Hash:** 558635f145955a6717eca87585a1b3d5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001062993-26-001166.hdr.sgml**: 20260226

**ACCESSION NUMBER**: 0001062993-26-001166

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20260225

**FILED AS OF DATE**: 20260226

**DATE AS OF CHANGE**: 20260225

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Zentek Ltd.
- **CENTRAL INDEX KEY:** 0001904501
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISCELLANEOUS CHEMICAL PRODUCTS [2890]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A6
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41310
- **FILM NUMBER:** 26680840

**BUSINESS ADDRESS:**
- **STREET 1:** 24 CORPORATE CT
- **CITY:** GUELPH
- **STATE:** A6
- **ZIP:** N1G 5G5
- **BUSINESS PHONE:** (844) 730-9822

**MAIL ADDRESS:**
- **STREET 1:** 24 CORPORATE CT
- **CITY:** GUELPH
- **STATE:** A6
- **ZIP:** N1G 5G5

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

For the month of <u>**February 2026**</u>

Commission File Number:<u>**001-41310**</u>

**<u>ZENTEK LTD.</u>**

(Registrant)

**24 Corporate Court**

<u>**Guelph, Ontario N1G 5G5 Canada**</u>

(Address of Principal Executive Offices)

Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☐ Form 40-F ☒

Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

------

<u>**SIGNATURES**</u><br>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **ZENTEK LTD.** | **ZENTEK LTD.** |
|  | (Registrant) | (Registrant) |
| Date: February 25, 2026 | By | /s/ Wendy Ford |
|  |  | Wendy Ford |
|  |  | Chief Financial Officer |

---

------

<u>**EXHIBIT INDEX**</u>

---

| | |
|:---|:---|
| **Exhibit** | <u>**Description of Exhibit**</u> |
| [99.1](exhibit99-1.htm) | [Press Release dated February 25, 2026 - Zentek Ltd. Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement](exhibit99-1.htm) |

---

------

## Exhibit 99.1

------

![](exhibit99-1x001.jpg)

**Zentek Ltd. Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement**

**Guelph, Ontario, February 25, 2026 - Zentek Ltd.** ("**Zentek**" or the "**Company**") (TSX-V: ZEN) (NASDAQ: ZTEK) announces that, further to its press release dated August 27, 2025, it has been granted a 180 calendar day extension from The Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Rule") for continued listing on Nasdaq (the "Minimum Bid Price Requirement"), following the expiration of the initial 180 calendar day period to regain compliance on February 23, 2026. The Company now has until August 24, 2026, to meet the Minimum Bid Price Requirement set forth in Nasdaq Listing Rule 5550(a)(2).

There is no immediate effect on the listing or trading of the Company's shares, which will continue to trade on the Nasdaq under the symbol "ZTEK." To regain compliance with the Rule, the Company must maintain a closing bid price of at least $1.00 per share for a minimum of ten (10) consecutive business days on or prior to August 24, 2026. Zentek's management intends to actively monitor the bid price for its Shares and will consider all available options to regain compliance with the Nasdaq minimum bid price requirement.

**About Zentek Ltd.**

Zentek Ltd. is a Canadian company advancing a portfolio of graphene-enabled advanced material technologies across healthcare, clean air and next-generation industrial applications. Zentek develops and scales materials-innovation solutions that aim to make partner products better, safer and more energy-efficient, while unlocking new high-value markets for ultra-high-purity graphite in nuclear, battery and semiconductor applications.

**For further information:**

Mohammed (Moe) Jiwan

Chief Executive Officer

Phone: 647-287-9582

Email: <u>mjiwan2@zentek.com</u>

------

![](exhibit99-1x001.jpg)

To find out more about Zentek, please visit our website at <u>www.Zentek.com</u>. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at <u>http://www.sedarplus.ca/</u>.

**Forward-Looking Statements**

This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek refuses any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

------